- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03221855
Use of Domperidone to Increase Milk Production in Mothers With Newborns in Neonatology
July 17, 2017 updated by: Hospital de Clinicas de Porto Alegre
Randomized Clinical Trial: Use of Domperidone to Increase Milk Production in Mothers With Newborns Hospitalized in Neonatology
It is a double-blind randomized clinical trial placebo-controlled, which aims to assess whether Domperidone medication helps to increase milk production.
The sample of 30 mothers of newborns in the Neonatal Intensive Care Unit of the Hospital de Clínicas de Porto Alegre for at least 15 days, receiving power enteral tube (without clinical condition for oral).
Nursing mothers will be evaluated by the researcher (breastfeeding committee member) or consultants in breastfeeding that will advise these women about the practice of runs out of the breasts each mother.
You receive containers for collection, at least one for each time you run out.
These containers will measure the volume of milk.
For each mother that refer insufficient milk production or is not maintaining adequate production for their newborn within 24 hours, one will be generated data form and after 15 days postpartum will be randomized and receive domperidone orally at a dose of 10mg 8/8 hours, or placebo in same volume.
The milk volume will be measured daily.
Three blood samples will be collected for each lactating each with 5 ml tube without anticoagulant for analysis of serum prolactin and domperidone.
The sample 01 will be collected immediately after randomization, before receiving any medication (placebo x domperidone).
The sample 02 on 5 of the study.
And the sample 03, day 10 of the study, three days after the termination of the use of medication or placebo.
A milk sample (5 ml) of each mother will be collected on day 5 to analysis of domperidone levels in milk.
Once collected, the samples will be processed and frozen at -80o C for later analysis.
All mothers will be followed until hospital discharge of their newborns, to monitor outcome breastfeeding exclusive breast.
Study Overview
Detailed Description
It is a clinical double-blind randomized placebo-controlled trial.
The sample consists of 30 mothers of newborns stable hemodynamically and are admitted to the Neonatal Intensive Care Unit of the Hospital de Clínicas de Porto Alegre for at least 15 days, receiving power via enteral tube (without clinical condition to oral).
The mothers will be assessed by the researcher (committee member of breastfeeding) or a lactation consultants who will advise women about these practice runs out of the breasts.
Breast milk is collected using a breast pump electric Lactinadouble, which enables the extraction of milk in both breasts simultaneously.
Every mother receive collection containers, at least one for every time you run out.
These containers will measure accurately the volume of milk.
Women will be instructed to use a new packaging for each pumping and not add the milk from two different milkings.
For every mother noted that insufficient milk supply or production is not suitable for keeping your newborn within 24 hours, it will generate an data form and after 15 days postpartum will be randomized and receive domperidone orally at a dose of 10mg of 8/8 hours or placebo in same volume.
The mothers included in the survey will receive record sheets and adhesive labels to record the amount of milk collected, the date and time.
The milk volume will be measured daily.
Three blood samples will be collected for each nurse, each with 5 ml tube analysis without anticoagulant for serum levels of prolactin and domperidone.
The sample 01 will be collected immediately after randomization, before receiving any medication (placebo x domperidone).
The sample 02 at day 5 of the study.
And the sample 03, the 10th day of the study, 3 days after the end of the medication or placebo.A milk sample (5 ml) of each mother will be collected on day 5 to analyzing levels of domperidone in the milk.
Once collected, the samples will be processed and frozen at-80o C for later analysis.
All mothers will be followed until discharge of their newborns, to monitor outcome breastfeeding exclusive breast.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil, 5505133597670
- Hospital de Clinicas de Porto Alegre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Mothers who report a decrease in the production of depleted milk.
- Mothers who do not have sufficient milk production to supply the baby's demand, according to the amount prescribed in the medical prescription.
- Mothers who are able to swallow tablets.
Exclusion Criteria:
-Mothers with the virus HIV.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Domperidone
Domperidone 10mg every 8 hours for 7 days.
|
Capsules 10mg orally each 8 hours for 7 days.
Other Names:
|
Placebo Comparator: Placebo
Placebo 10mg every 8 hours for 7 days.
|
Capsules 10mg orally each 8 hours for 7 days.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Increase the production of breast milk of nursing mothers who are with their newborns admitted to the neonatal. Milk production measured by volume (ml) for 10 days.
Time Frame: 10 days
|
Increase the production of breast milk of nursing mothers who are with their newborns admitted to the neonatal, failing to provide this Baby breastfed during their hospital stay.
|
10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Rita de Cassia C. Silveira, Hospital de Clinicas de Porto Alegre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Giugliani ER. [Breast-feeding in clinical practice]. J Pediatr (Rio J). 2000 Nov;76 Suppl 3:S238-52. doi: 10.2223/jped.161. Portuguese.
- Charpak N, Ruiz-Pelaez JG, Figueroa de C Z, Charpak Y. A randomized, controlled trial of kangaroo mother care: results of follow-up at 1 year of corrected age. Pediatrics. 2001 Nov;108(5):1072-9. doi: 10.1542/peds.108.5.1072.
- Zuppa AA, Sindico P, Orchi C, Carducci C, Cardiello V, Romagnoli C. Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production. J Pharm Pharm Sci. 2010;13(2):162-74. doi: 10.18433/j3ds3r.
- Gabay MP. Galactogogues: medications that induce lactation. J Hum Lact. 2002 Aug;18(3):274-9. doi: 10.1177/089033440201800311.
- Anderson PO, Valdes V. A critical review of pharmaceutical galactagogues. Breastfeed Med. 2007 Dec;2(4):229-42. doi: 10.1089/bfm.2007.0013.
- da Silva OP, Knoppert DC, Angelini MM, Forret PA. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. CMAJ. 2001 Jan 9;164(1):17-21.
- Wan EW, Davey K, Page-Sharp M, Hartmann PE, Simmer K, Ilett KF. Dose-effect study of domperidone as a galactagogue in preterm mothers with insufficient milk supply, and its transfer into milk. Br J Clin Pharmacol. 2008 Aug;66(2):283-9. doi: 10.1111/j.1365-2125.2008.03207.x. Epub 2008 Apr 21.
- Djeddi D, Kongolo G, Lefaix C, Mounard J, Leke A. Effect of domperidone on QT interval in neonates. J Pediatr. 2008 Nov;153(5):663-6. doi: 10.1016/j.jpeds.2008.05.013. Epub 2008 Jun 27.
- Campbell-Yeo ML, Allen AC, Joseph KS, Ledwidge JM, Caddell K, Allen VM, Dooley KC. Effect of domperidone on the composition of preterm human breast milk. Pediatrics. 2010 Jan;125(1):e107-14. doi: 10.1542/peds.2008-3441. Epub 2009 Dec 14.
- Zavitsanos AP, MacDonald C, Bassoo E, Gopaul D. Determination of domperidone in human serum and human breast milk by high-performance liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl. 1999 Jun 25;730(1):9-24. doi: 10.1016/s0378-4347(99)00163-2.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
September 16, 2016
First Submitted That Met QC Criteria
July 17, 2017
First Posted (Actual)
July 19, 2017
Study Record Updates
Last Update Posted (Actual)
July 19, 2017
Last Update Submitted That Met QC Criteria
July 17, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-0197
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breastfeeding
-
Marmara UniversityNot yet recruitingBreastfeeding | Breastfeeding Support
-
University of CopenhagenDanish Committee for Health Education; Nordea-fonden; Det Obelske Familiefond; 21...Recruiting
-
Halic UniversityCompletedBreastfeeding | Breastfeeding, ExclusiveTurkey
-
University of Ontario Institute of TechnologyDurham Region Health DepartmentUnknown
-
University of California, DavisUniversity of California, San Francisco; Public Hospital Roatan, HondurasCompletedBreastfeeding | Breastfeeding, ExclusiveHonduras
-
University of Mississippi Medical CenterRecruitingBreastfeeding | Breastfeeding, ExclusiveUnited States
-
Celal Bayar UniversityManisa Celal Bayar UniversityCompletedBreastfeeding | Breastfeeding, ExclusiveTurkey
-
Benten Technologies, Inc.National Institute on Minority Health and Health Disparities (NIMHD); George... and other collaboratorsEnrolling by invitationBreastfeeding | Exclusive BreastfeedingUnited States
-
The University of Hong KongCompletedBreastfeeding | Breastfeeding, ExclusiveHong Kong
-
Albert Einstein College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedBreastfeeding | Breastfeeding, ExclusiveUnited States
Clinical Trials on Domperidone
-
Hamilton Health Sciences CorporationThe Physicians' Services Incorporated FoundationTerminatedInsufficient Breastmilk ProductionCanada
-
University of CalgaryAlberta Innovates Health SolutionsCompletedMultiple Sclerosis, Secondary ProgressiveCanada
-
Arnold, George, M.D.Unknown
-
David J. Lederer, M.D.TerminatedGastroesophageal Reflux | GastroparesisUnited States
-
Eastern Regional Medical CenterAvailableOncology Patients With GastroparesisUnited States
-
University of CalgaryAlberta Innovates Health SolutionsCompletedMultiple Sclerosis, Relapsing-RemittingCanada
-
Nantes University HospitalCompletedPrematurity and Feeding IntoleranceFrance
-
Aurora Health CareAvailable
-
University Health Network, TorontoTerminatedParkinson's Disease | Peripheral EdemaCanada